LJPC
La Jolla Pharmaceutical Company
LJPC
LJPC
Delisted
LJPC was delisted on the 19th of August, 2022.
75 hedge funds and large institutions have $219M invested in La Jolla Pharmaceutical Company in 2019 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 26 increasing their positions, 18 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
29% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 14
Holders
75
Holding in Top 10
3
Calls
$717K
Puts
$611K
Top Buyers
| 1 | +$3.78M | |
| 2 | +$2.64M | |
| 3 | +$1.76M | |
| 4 |
D.E. Shaw & Co
New York
|
+$989K |
| 5 |
Invesco
Atlanta,
Georgia
|
+$748K |
Top Sellers
| 1 | -$12.1M | |
| 2 | -$6.39M | |
| 3 | -$6.25M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$4.39M |
| 5 |
FI
Fosun International
Hong Kong,
China
|
-$3.74M |